LivaNova PLC
NASDAQ:LIVN

Watchlist Manager
LivaNova PLC Logo
LivaNova PLC
NASDAQ:LIVN
Watchlist
Price: 46.75 USD -0.51%
Market Cap: 2.5B USD
Have any thoughts about
LivaNova PLC?
Write Note

LivaNova PLC
Investor Relations

LivaNova PLC is a dynamic player in the realm of medical technology, with its roots tracing back to the merger of two well-established entities, Sorin Group and Cyberonics, in 2015. This union was more than just a blending of operations; it marked the convergence of expertise in cardiac surgery and neuromodulation. Headquartered in London, LivaNova set out with a mission to innovate within the treatment space for life-critical conditions, making a name for itself in the healthcare sector by focusing on two principal areas: cardiovascular solutions and neuromodulation therapy. These areas aren't just buzzwords; they represent the backbone of the company’s operations, serving critical patient needs with a near-requirement for continuous technological advancement.

LivaNova's revenue streams are primarily derived from its cutting-edge products used in life-sustaining procedures and therapeutic interventions. In cardiovascular solutions, the company excels with its offerings in heart-lung machines, used in cardiac surgeries, and heart valves, instrumental in treating heart valve disease. Meanwhile, their neuromodulation division stands at the forefront of treating refractory epilepsy and depression with devices that deliver electrical impulses to the vagus nerve. By continuously pushing the envelope on medical tech, LivaNova not only ensures reliable outcomes for patients but also maintains a robust portfolio that draws revenues from hospitals and clinics worldwide. This balance of innovative prowess and strategic product deployment is what enables LivaNova to mitigate risks and sustain its financial health amidst the volatile landscape of the global healthcare market.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Michael D. Hutchinson
Senior VP, Chief Legal Officer & Company Secretary
No Bio Available
Mr. Vladimir A. Makatsaria
CEO & Director
No Bio Available
Deanna Wilke
Vice President of Corporate Communications
No Bio Available
Mr. Matthew Joseph Dodds III
Senior Vice President of Corporate Development & IT
No Bio Available
Mr. Paul R. Buckman
President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement
No Bio Available
Ms. Stephanie Bolton
President of Global Epilepsy
No Bio Available
Ahmet Tezel Ph.D.
Chief Innovation Officer
No Bio Available
Mr. Franco Poletti
President of Cardiopulmonary Business Unit
No Bio Available
Mr. John Webb
Vice President of Sleep Apnea and Epilepsy
No Bio Available
Mr. Jonathan Walker
VP for Difficult-to-Treat Depression Segment
No Bio Available

Contacts

Address
London
20 Eastbourne Terrace
Contacts
+442033250662.0
www.livanova.com